chrisvoncsefalvay/vaers-outcomes huggingface dataset:
abdominal pain; headache; vomiting; body aches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal pain), HEADACHE (headache), VOMITING (vomiting) and MYALGIA (body aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 06-Dec-2020. Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN), MULTIVITAMINS [VITAMINS NOS] and PROGESTERONE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ABDOMINAL PAIN (abdominal pain), HEADACHE (headache), VOMITING (vomiting) and MYALGIA (body aches). At the time of the report, ABDOMINAL PAIN (abdominal pain), HEADACHE (headache), VOMITING (vomiting) and MYALGIA (body aches) outcome was unknown.            Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-065501 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065501:Dose 1
Had moderna as my first two covid shots and just got a booster (in my left arm) of Pfizer 2 days ago. This morning, I woke up with the lymph nodes on my left collarbone and left armpit very swollen. I was reading online that this is only reported in 0.3% of boosted people but two other co workers both had that happen to them so I thought I should report my side effects so that the true numbers can be seen. Took 2 advil when I got to work since it would hurt when I pushed down on my collar bone lymph node. Thanks.
tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP).  A 66-year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 66 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE, Batch/lot number: Unknown, Manufacturer: Unknown), for COVID-19 immunisation. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "tinnitus".  Additional information: As per source, it was the shock of a loud whistle that almost caused Patient to veer off the road as he was driving home after getting his second COVID-19 vaccine. Patient thought it was a dog whistle going off right next to him. It was not a dog whistle; it was a piercing sound his brain conjured up for an unknown reason. Patient suspected it may have been a side effect of the vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Child c/o swelling w/redness on R/A. Arm felt hot by touch. Advised mom to rest in ice. Vaccine PROQUAD R/A.
Child reported to mother blisters on body 6/2/06. Mother took child to the emergency room where he was Dx with chickenpox disease. No fever.
High fever 101degF for 36 hrs, headache, muscle pain, joints pain, stomach discomfort.  Took Tylenol every 6 hrs.
came to ER 12/25/21 after 1-2 wk h/o cough DC home 12/27/21 as was felt stable only to return to ER 12/29/21 in resp distress and died on 1/1/22
pt recvd vax;couple of days later exp groin rash,spread out to full body rash;tx hismanal,decadron,sterapred,oth antihistamines;rash caused hands to swell,itch;on biaxin x 5days for upper resp infect,was pre-existent to the start of vax;
Employee c/o lips prickly and throat scratchy at 1352. Benadryl 25 mg administered. V/s b/p:  123/85 P:100 o2:97. At 1430 employee complained that the symptoms had not subsided. Benadryl 25 mg administered. At 1450 employee stated she felt much better and she left observation area.
Pt experience nausea, lightheadness. Pt vomited two times. 911 called and vitals were ok. Pt went home and rested and felt better.
First, I had a swollen spot on my arm, the doctor said it was normal. Then, I began to have pain in my legs, they were stiff and painful to move. It lasted for 8 weeks, the doctor told me to walk around and take ibuprofen.
Vomiting, fever, chills-reddened skin at injection site. Occurred ~ 24 hours post injection. Given Phenogan suppontones, ice packs to site, analgesics for discomfort. Unable to reach pt.
night sweets; felt sick all the time; left arm hurts and feels sore; fever; chills; exhausted; nausea; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (night sweets), MALAISE (felt sick all the time), VACCINATION SITE PAIN (left arm hurts and feels sore), PYREXIA (fever) and CHILLS (chills) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fruit allergy (orange) and Drug allergy (Codeine).   On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NIGHT SWEATS (night sweets), MALAISE (felt sick all the time), VACCINATION SITE PAIN (left arm hurts and feels sore), PYREXIA (fever), CHILLS (chills), FATIGUE (exhausted) and NAUSEA (nausea). At the time of the report, NIGHT SWEATS (night sweets), MALAISE (felt sick all the time), PYREXIA (fever), CHILLS (chills), FATIGUE (exhausted) and NAUSEA (nausea) had resolved and VACCINATION SITE PAIN (left arm hurts and feels sore) had not resolved.            No concomitant medications were reported.  No treatment medications were reported.  At the time of reporting patient's left arm was not red. Patient had a virtual meeting with HCP.
This spontaneous report as received from a pharmacist refers to a 66 year old male patient. The patients current conditions or medical history were reported as none. On 05-MAR-2014 the patient was vaccinated with ZOSTAVAX (dose and route were not reported) (lot number reported as J011828 expiry 26-DEC-2020). Concomitant therapies included HAVRIX administered at the same time as ZOSTAVAX in the patient's opposite arm. On 06-MAR-2014, the patient developed a 2 inch, red rash at the ZOSTAVAX injection site. The pharmacist reported that the patient went to the pharmacy on 07-MAR-2014 and the 2 inch red rash was still present at the injection site. At the time of the report the patient was not recovered from 2 inch red rash at the injection site. The patient did not receive treatment for the event. Additional information has been requested.
fever, lt arm rash- 10 days p/vax;seen by MD tx symptomatically;
Syringe leaked during vaccine administration.  A second dose was successfully administered in the other arm.
I noticed that my injection site is the size of a baseball, its red, and itchy. It is also warm to the touch.
Patient presented to County Health Covid vaccine clinic for Pfizer booster vaccine. RN administered Pfizer booster vaccine (Lot# FF8841) in left deltoid at 11:30 am. Patient left clinic area at 11:45 am. with no adverse reaction. At 3:20 pm patient arrived back at ACHD, presents with a red raised clustered rash on bilateral forearms with itching, and c/o right jaw numbness. Patient was assessed by FNP. Ordered Benedryl 50mg IM one time. and instructed patient to report to ER if difficulty breathing or trouble swallowing occurs. Benedryl 50 mg IM administered in right deltoid by LPN, patient monitored for 20 minutes post injection. Patient tolerated well. Patient left at 3:55 pm with no further complaints or symptoms. VS: B/P 126/74 , HR 85, 02 sat: 95%.
5 cm redness R thigh.  2.5 cm redness L thigh.  Tx: Tylenol and Motrin.
Presents to the ED c/o SOB. Positive for Covid on day of admission 1/25/22. History is obtained from daughter at bedside. She says her mom has been feeling SOB for the past 5 days, along with lethargy and poor po intake. She has not been having any coughs, fevers, chills. She has supplemental O2 at home that she does not use. She has been vaccinated against COVIDx2. She was unable to come off of BIPAP. I did have a long discussion with the family. They would like to make the patient hospice and initate CMO. She has transferred and made CMO. Patient passed comfortably.
Early 3/26/21, I experienced low grade fever, chills, and shaking.  About 9 hours later, I became light-headed and fainted.  I broke my left wrist on a coffee table after losing consciousness on the way down.  Wrist was in splint for 4 weeks.  8 weeks later I am still receiving occupational therapy to regain motility/strength.
Covid arm bump/rash at sight,  7 days after shot Itchy and irritated,  growing bigger
This spontaneous report as received from a pharmacist refers to a 67 years old female patient. The patient was vaccinated with a dose of ZOSTAVAX (lot # 671786/0254AE) (Subcutaneous in left arm) on 11-SEP-2012. Other suspect therapies included FLUZONE (lot# was unknown) on 11-SEP-2012 in the same arm at the same visit for ZOSTAVAX. There was no concomitant medications. After one week vaccination, on 18-SEP-2012 the patient experienced pain and burning at the ZOSTAVAX injection site. The patient experienced the pain when she moved her arm back and up. The patient contacted physician for medical attention and unspecified antibiotic was given for the adverse events. The outcome of pain and burning at the ZOSTAVAX injection site was reported as not recovered/not resolved. Additional information is not expected.
Broke out in maculopapular rash over entire cutaneous area.  No prior history of adverse reaction to vaccine.  No egg allergy.
diffuse inflammation of the brachial plexu; loss of range of motion,  loss of strength in abduction and his external humerus, and his other systems are mildly weak.; loss of strength in abduction and his external humerus; after the 2nd dose, 8 hours later his arm started to hurt a lot, like someone had put an ice pick in his shoulder.; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIC AMYOTROPHY (diffuse inflammation of the brachial plexu), MOBILITY DECREASED (loss of range of motion,  loss of strength in abduction and his external humerus, and his other systems are mildly weak.), ASTHENIA (loss of strength in abduction and his external humerus) and MYALGIA (after the 2nd dose, 8 hours later his arm started to hurt a lot, like someone had put an ice pick in his shoulder.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 025320A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN for Cholesterol, NADOLOL and MAGNESIUM for Long QT syndrome.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NEURALGIC AMYOTROPHY (diffuse inflammation of the brachial plexu), MOBILITY DECREASED (loss of range of motion,  loss of strength in abduction and his external humerus, and his other systems are mildly weak.), ASTHENIA (loss of strength in abduction and his external humerus) and MYALGIA (after the 2nd dose, 8 hours later his arm started to hurt a lot, like someone had put an ice pick in his shoulder.). At the time of the report, NEURALGIC AMYOTROPHY (diffuse inflammation of the brachial plexu), MOBILITY DECREASED (loss of range of motion,  loss of strength in abduction and his external humerus, and his other systems are mildly weak.), ASTHENIA (loss of strength in abduction and his external humerus) and MYALGIA (after the 2nd dose, 8 hours later his arm started to hurt a lot, like someone had put an ice pick in his shoulder.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.
Breakthrough case admission after 4 vaccines mOderna 1/13/21 Lot# 011L20A;  Moderna 2/10/21 Lot# 011L20A;  Moderna 11/3/21 Lot# 071F21A;  Moderna 5/5/22 Lot# 065k21A
had a reaction; Initial information regarding this unsolicited valid non-serious case received from a consumer (patient) via social media Facebook on 13-Nov-2020.  This case involves an unknown demographic patient who had a reaction (Adverse reaction), after receiving INFLUENZA VACCINE.  Medical history, medical treatment, vaccination and family history of the patient were not provided. Concomitant medication was not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date (unknown latency), the patient had a reaction (Adverse reaction), following the administration of INFLUENZA VACCINE.  No relevant laboratory test was reported.  It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown.  There will be no information available on batch number for this case.
right  shoulder hurt for a day after vaccine major nausea  sat-till now promethazine coughing up mucus sat-sun resolved on its own dizzy sat-till wed blood transfusion
One week after swollen hard and hot lump near injection site. Red skin approx 3 x 4 inches. Itchy and tender.
The patient stated that she developed a rash with swelling, redness and raised red bumps on her arm after the vaccine.  Stated the affected area was from her shoulder to her elbow and lasted about a week.  She stated the rash has mostly resolved.
Chest pains, shortness of breath, and heart palpitations began and were off and on.  Symptoms gradually worsened.  Shortness of breath was most pronounced symptom.  Unable to lay back and it was easier to breathe when leaning forward.  Went to the ER on 11/10/21.  Chest Ct scan was normal and was released.  Symptoms worsened and returned to ER 11/12/21.  I was admitted.  Cardiologist thought symptoms fell in line with pericarditis.  Blood work, stress test, and echocardiogram ruled out everything else.  I was given colchicine.  Symptoms improved and I was released on 11/13/21.  Treatment is to continue colchicine for one week and follow up with cardiologist.
Approx 2hrs p/vax fever up to 105; Tx APAP, hx of vomiting x 1, listless; WBC below;
Scratchy throat, dry cough, crusty eyes, achy muscles, tired, fever nausea.
Arm sore near injection site; Arm sore near injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Aug2021 at 09:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in Aug2021, the patient experienced arm sore near injection site. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of event arm sore near injection site was unknown at the time of this report.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up
COULD NOT HAD ANYTHING TOUCH ENTIRE ARM; SICK; CHILLS; FEVER; HEADACHE; FATIGUE; ACHING MUSCLE; THE INJECTION HURTS EXTREMELY BAD AND WAS SWOLLEN; THE INJECTION HURTS EXTREMELY BAD AND WAS SWOLLEN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced could not had anything touch entire arm. On APR-2021, the subject experienced sick. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. On APR-2021, the subject experienced fatigue. On APR-2021, the subject experienced aching muscle. On APR-2021, the subject experienced the injection hurts extremely bad and was swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, headache, fatigue, aching muscle, the injection hurts extremely bad and was swollen, the injection hurts extremely bad and was swollen, could not had anything touch entire arm, and sick. This report was non-serious.
PT CAME IN FOR SHINGRIX SHOT. SHE REMOVED HER SWEATER FROM HER RIGHT ARM AND SAT DOWN FOR THE INJECTION. I PROCEEDED TO TELL HER THE SIDE EFFECTS OF THE VACCINE, ETC. I ADMINISTERED THE VACCINE. PT TRIED TO GET UP FROM THE SITTING POSITION BUT HAD SOME DIFFICULTY. SHE TRIED TO GET SOME LEVERAGE WITH THE COUNTER. I TRIED HELPING HER UP BUT COULDN'T GET HER STANDING. PT IS ON CHRONIC OXYGEN AND HAD HER OXYGEN GOING. WHEN I COULDN'T GET HER STANDING, I SAT HER BACK DOWN IN THE CHAIR. SHE BECAME UNRESPONSIVE TO COMMENTS, COMMANDS, INTERACTION OF ANY KIND. SHE HAD HER EYES CLOSED, WAS BREATHING NORMALLY, HAD GOOD COLOR, AND HAD A REGULAR PULSE (PULSE WAS CHECKED BY A NURSE CUSTOMER WHO WAS HERE AT THE TIME. AT THAT TIME WE PAGED HUSBAND AND CALLED HIS CELL NUMBER WITH NO RESPONSE. PT'S HUSBAND CAME IN SHORTLY THEREAFTER. HE WAS WAITING IN THE CAR FOR HER. HE CHECKED HER OXYGEN AND TURNED IT UP. WE CALLED 911. IN THE INTERIM WE TRIED COMMUNICATING WITH PATIENT AND TRIED GETTING HER TO RESPOND. 911 ARRIVED AND TOOK OVER. PT'S HUSBAND LEFT WITH PATIENT. THE NEXT DAY PT'S HUSBAND CAME IN AND TOLD ME SHE HAD HAD A MASSIVE CEREBRAL BLEED AND WASN'T EXPECTED TO RECOVER. AT NO TIME DID HE INDICATE THAT HE THOUGHT IT WAS FROM THE SHOT. THE NEXT DAY I SPOKE TO THE PT'S DOCTOR AND HE TOO DIDN'T THINK IT WAS DUE TO THE VACCINE AND THAT THE TIMING WAS COINCIDENTAL. AT THIS TIME, I DO NOT KNOW IF THE PT IS CURRENTLY IN THE HOSPITAL OR HAS PASSED AWAY.
bad reaction to vaccine/Ended up in E.R.. couldn't breathe; This case was reported by a consumer via interactive digital media and described the occurrence of difficulty breathing in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced difficulty breathing. On an unknown date, the outcome of the difficulty breathing was unknown.   It was unknown if the reporter considered the difficulty breathing to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a bad reaction to vaccine, could not breathe and was ended up in emergency room  .
Patient was under the minimum age of 18 at the time of vaccine by 2 months. Patient experienced mild dizziness after vaccination and called a family member to drive her home
Covid-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid-19) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058hala, 041c21a and 032b21a) for COVID-19 vaccination.     The patient had no history of acute and chronic illnesses at the time of vaccination.  Previously administered products included for Product used for unknown indication: Flu vaccination (He got sick after a flu vaccine.) in 2014. Past adverse reactions to the above products included Sickness with Flu vaccination. Concurrent medical conditions included Non-smoker (no smoking).   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown.            Concomitant medication include a couple of blood pressure pills. Patient stated that he do not drink, or take drugs and had been quarantined for ten days. No treatment medications was provided by the reporter.  Company comment: This is a spontaneous case concerning a 67-year-old, male patient with no relevant medical history. Patient has vaccination history of receiving first and second dose of mRNA-1273 vaccine with appropriate dosage interval of 28 days. Patient experienced the unexpected non-serious event of Covid-19. The event occurred approximately 211 days after the third dose of mRNA-1273 vaccine administration. No other information surrounding the event was reported. The outcome of the event was unknown. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-604299 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 67-year-old, male patient with no relevant medical history. Patient has vaccination history of receiving first and second dose of mRNA-1273 vaccine with appropriate dosage interval of 28 days. Patient experienced the unexpected non-serious event of Covid-19. The event occurred approximately 211 days after the third dose of mRNA-1273 vaccine administration. No other information surrounding the event was reported. The outcome of the event was unknown. The current Covid-19 pandemic remain confounder for the event. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
he woke up today with a headache; he did not sleep well due to pain from a stubbed toe; he did not sleep well due to pain from a stubbed toe; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 29-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER2613), via intramuscular, administered in Arm Right on 23Mar2021 (at the age of 29-year-old) as dose 1, single for covid-19 immunisation. Medical history included none. There were no concomitant medications. On 23Mar2021, the patient experienced he did not sleep well due to pain from a stubbed toe. On 24Mar2021, patient experienced he woke up today with a headache. The outcome of the event he did not sleep well due to pain from a stubbed toe was unknown and outcome of the event he woke up today with a headache was recovering.  No follow-up attempts are possible. No further information is expected.